Digitalisation & Artificial Intelligence

Objectives

In this conference session, we will provide a comprehensive overview of the current state of digitalisation and the use of artificial intelligence in the pharmaceutical industry. You will learn how digitalisation can be implemented to increase efficiency and improve quality. A variety of case studies from pharmaceutical companies will be used to present practical projects.

Background

New forms and approaches to digitalisation are increasingly finding their way into the pharmaceutical industry. While automation is already well advanced, topics such as AI, IoT and Industry 4.0 are in the early stages of development. Since the release of Chat GPT and Bard, artificial intelligence has become a commonplace technology in many sectors, including the pharmaceutical industry.

Therefore, the agenda for the track will also include artificial intelligence, with a presentation and discussion of initial experiences from established projects. The focus is on GxP-relevant aspects from the perspective of the pharmaceutical industry and regulatory authorities.

Target Audience

The event is directed at specialists from the pharmaceutical industry as well as at engineers and planners who have to deal with digitalisation and AI projects.

It particularly addresses the departments:

• IT
• Production
• Quality assurance
• Engineering / Technology

 

You can find more detailed information at a later time.